针对《癌症治疗药物甲磺酸伊马替尼的心脏毒性》的回复 - Suppr

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

作者信息

Atallah Ehab, Kantarjian Hagop, Cortes Jorge

出版信息

Nat Med. 2007 Jan;13(1):14; author reply 15-6. doi: 10.1038/nm0107-14.

DOI:10.1038/nm0107-14

PMID:17206119

Abstract

摘要

相似文献

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):14; author reply 15-6. doi: 10.1038/nm0107-14.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):15; author reply 15-6. doi: 10.1038/nm0107-15a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13; author reply 15-6. doi: 10.1038/nm0107-13a.

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

Nat Med. 2007 Jan;13(1):13-4; author reply 15-6. doi: 10.1038/nm0107-13b.

Cardiotoxicity of imatinib: At the heart of the problem.

Leuk Res. 2011 Jan;35(1):36-7. doi: 10.1016/j.leukres.2010.09.021.

Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).

Ann Hematol. 2004;83 Suppl 1:S65-6. doi: 10.1007/s00277-004-0850-2.

Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.

Oncologist. 2005 Jun-Jul;10(6):457-8. doi: 10.1634/theoncologist.10-6-457.

Imatinib mesylate.

Rev Gastroenterol Disord. 2002;2(2):75-86.

J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.

Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.

Haematologica. 2004 Sep;89(9):ECR32.

引用本文的文献

Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies.

Med Sci (Basel). 2025 Aug 14;13(3):130. doi: 10.3390/medsci13030130.

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro-cardio-oncology.

Cancer Innov. 2024 Feb 5;3(2):e108. doi: 10.1002/cai2.108. eCollection 2024 Apr.

Imatinib Mesylate Induces Necroptotic Cell Death and Impairs Autophagic Flux in Human Cardiac Progenitor Cells.

Int J Mol Sci. 2022 Oct 5;23(19):11812. doi: 10.3390/ijms231911812.

Association of Cardiotoxicity With Doxorubicin and Trastuzumab: A Double-Edged Sword in Chemotherapy.

Cureus. 2021 Sep 22;13(9):e18194. doi: 10.7759/cureus.18194. eCollection 2021 Sep.

Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.

Curr Hematol Malig Rep. 2020 Feb;15(1):20-30. doi: 10.1007/s11899-020-00560-x.

From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Antioxid Redox Signal. 2019 Jun 20;30(18):2110-2153. doi: 10.1089/ars.2016.6930. Epub 2017 May 15.

Cardiotoxicity associated with targeted cancer therapies.

Mol Clin Oncol. 2016 May;4(5):675-681. doi: 10.3892/mco.2016.800. Epub 2016 Mar 3.

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.

Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.

J Clin Oncol. 2015 Dec 10;33(35):4210-8. doi: 10.1200/JCO.2015.62.4718. Epub 2015 Sep 14.

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Biologics. 2010 Dec 2;4:315-23. doi: 10.2147/BTT.S5775.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献